 DURHAM, N.C., Oct. 06, 2021 GLOBE NEWSWIRE -- Heat Biologics, Inc. Heat NASDAQ: HTBX, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced the appointment of Paul Tebbey, Ph.D. as Senior Vice President of Product Development and Portfolio Strategy. 